Παρασκευή 1 Νοεμβρίου 2019


Pulsed Reduced Dose Rate for Reirradiation of Recurrent Breast Cancer
ConclusionsPRDR radiation therapy with capecitabine was a well-tolerated and effective method for treating patients with recurrent breast cancer. Prospective studies are necessary to compare side effects and efficacy with conventional dose rate reirradiation and to evaluate the potential role for capecitabine in the recurrent setting. (Source: Practical Radiation Oncology)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:44
Letter to the editor concerning “Single-institution experience of performing bloodless transplant in Jehovah’s Witness patients” by Coltoff A, Aditya S, Solmaz A, and Steinberg A. (Hematol oncol stem cell ther 2019;12(1):44–9.)
Publication date: Available online 11 October 2019Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Jennifer C. Zhao, Justin R. Arnall, Allison L. Martin, Saad Usmani, Shebli Atrash (Source: Hematology Oncology and Stem Cell Therapy)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:44
Analysis of the efficacy of thalidomide plus dexamethasone-based regimens in patients with relapsed/refractory multiple myeloma who received prior chemotherapy, including bortezomib and lenalidomide: KMM-166 study
ConclusionThalidomide-based regimens are potential salvage treatment options for patients with RRMM, even with prior resistance to IMiDs. (Source: Clinical Lymphoma Myeloma and Leukemia)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:44
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center
ConclusionOutpatient ASCT is a safe and feasible treatment strategy with low transplant-related mortality. Overall resource utilization is significantly lower than inpatient ASCT: however, this requires a multidisciplinary approach with close follow-up. (Source: Clinical Lymphoma Myeloma and Leukemia)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:44
Editorial Board
Publication date: November 2019Source: Cancer Genetics, Volume 239Author(s): (Source: Cancer Genetics)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:44
Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s)
Publication date: Available online 30 October 2019Source: Biochimica et Biophysica Acta (BBA) - Reviews on CancerAuthor(s): Joseph Carmicheal, Asish Patel, Vipin Dalal, Pranita Atri, Amaninder S. Dhaliwal, Uwe A. Wittel, Mokenge P. Malafa, Geoffrey Talmon, Benjamin J. Swanson, Shailender Singh, Maneesh Jain, Sukhwinder Kaur, Surinder K. BatraAbstractPancreatic ductal adenocarcinoma (PDAC) is an incredibly deadly disease with a 5-year survival rate of 6%. The presence of pancreatic cystic lesions...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:44
Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions
Publication date: Available online 31 October 2019Source: Biochimica et Biophysica Acta (BBA) - Reviews on CancerAuthor(s): Urvi H. Gala, Dave A. Miller, Robert O. WilliamsAbstractThe treatment of cancer is still a major challenge. But tremendous progress in anticancer drug discovery and development has occurred in the last few decades. However, this progress has resulted in few effective oncology products due to challenges associated with anticancer drug delivery. Oral administration is the most...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:44
Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia
This study combines metabolomics and gut microbiota diversity analysis to explore metabolic changes using a rat model as well as the changes in intestinal flora composition. The results showed that amino acid metabolism was disturbed with serine, glutamate and glutamine being downregulated whilst glycine, hydroxyproline and alanine being upregulated. The combined glycine, serine and glutamate could predict hyperuricemia nephropathy with an area under the curve of 1.00. Imbalanced intestinal flora...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:44
A systematic strategy for screening therapeutic constituents of Schisandra chinensis (Turcz.) Baill infiltrated blood-brain barrier oriented in lesions using ethanol and water extracts: A novel perspective for exploring chemical material basis of herb medicines
In this study, to explore the active constituents of S. chinensis, we compared pharmacodynamics and chemical profiles in vitro/in vivo of EES/WES for the first time using multiple chemical analysis, pharmacological and data processing approaches. It was proved that there was no significant difference in the anti-depressive effects between WES and EES. However, the contents of most components in vitro and in plasma were higher in EES than those in WES, which was unconvincing for their similar efficacy....
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:44
High Recurrence Rate of Myxofibrosarcoma: The Effect of Radiotherapy Is Not Clear.
Conclusions: The rate of LR for patients with myxofibrosarcoma was high. The impact of RT on local tumor control was unclear. The surgical margin was important for both local and distant tumor control. Large tumor size was a risk factor for distant metastasis. PMID: 31662702 [PubMed] (Source: Sarcoma)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:05
Nanovectors Design for Theranostic Applications in Colorectal Cancer.
Authors: Rampado R, Crotti S, Caliceti P, Pucciarelli S, Agostini M Abstract Colorectal cancer (CRC) is a diffused disease with limited therapeutic options, none of which are often curative. Based on the molecular markers and targets expressed by the affected tissues, numerous novel approaches have been developed to study and treat this disease. In particular, the field of nanotechnology offers an astonishingly wide array of innovative nanovectors with high versatility and adaptability...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:04
Cancer Survival by Stage at Diagnosis in Kuwait: A Population-Based Study.
Conclusion: Since stage-specific survival is similar in Kuwait and the US, late stage at diagnosis is likely to be a major contributing factor to the overall lower survival in Kuwait than in the US. Increasing public awareness of cancer risk factors and symptoms and investment in early detection will be vital to reduce the proportion of patients diagnosed at a late stage and to improve survival. PMID: 31662756 [PubMed] (Source: Journal of Oncology)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:04
IL-2 Induces Transient Arrest in the G1 Phase to Protect Cervical Cancer Cells from Entering Apoptosis.
We report that IL-2R is expressed in cervical cancer cells. IL-2 decreases cervical cancer cell proliferation via transient arrest of the G1 phase, which does not result in apoptosis or senescence. IL-2 upregulates the expression of p53 and p21 and downregulates cyclin D. In addition, we report the resistance of cervical cancer cells to treatments that induce apoptosis in HeLa and INBL cells. When arrested cells were treated with cisplatin, the cytokine protected cells from apoptosis induced by cisplatin....
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:04
The Role of Tumor-Infiltrating B Cells in Tumor Immunity.
Authors: Guo FF, Cui JW Abstract Earlier studies on elucidating the role of lymphocytes in tumor immunity predominantly focused on T cells. However, the role of B cells in tumor immunity has increasingly received better attention in recent studies. The B cells that infiltrate tumor tissues are called tumor-infiltrating B cells (TIBs). It is found that TIBs play a multifaceted dual role in regulating tumor immunity rather than just tumor inhibition or promotion. In this article, latest research...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:04
Intraoperative Ultrasound Staging for Colorectal Liver Metastases in the Era of Liver-Specific Magnetic Resonance Imaging: Is It Still Worthwhile?
Conclusions: IOUS improves staging in patients undergoing resection for CRLMs even in the era of liver-specific MRI. Intraoperative detection of new CRLMs negatively affects oncologic outcomes. PMID: 31662749 [PubMed] (Source: Journal of Oncology)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:04
Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced Melanoma.
Conclusion: Anti-PD-1 antibody-containing regimen was safe and effective in Chinese patients with advanced melanoma, and elevated CRP and ECOG score were independent factors predicting the efficacy of anti-PD-1 therapy. PMID: 31662753 [PubMed] (Source: Journal of Oncology)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:04
The Four Horsemen in Colon Cancer.
Authors: Hernández-Luna MA, López-Briones S, Luria-Pérez R Abstract Worldwide, neoplasms of the gastrointestinal tract have a very high incidence and mortality. Among these, colorectal cancer, which includes colon and rectum malignancies, representing both highest incidence and mortality. While gallbladder cancer, another neoplasm associated to gastrointestinal tract occurs less frequently. Genetic factors, inflammation and nutrition are important risk factors associated with colorectal...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:04
MicroRNA-181a Inhibits Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Progression by Repressing CARD11.
Authors: Zhu D, Fang C, He W, Wu C, Li X, Wu J Abstract We investigated the role of miR-181a in diffuse large B-cell lymphoma (DLBCL) and its potential target genes. miR-181a levels were lower in activated B-cell- (ABC-) like DLBCL cells than that in germinal center B-cell- (GCB-) like DLBCL cells. Overexpression of miR-181a in ABC-like DLBCL cell lines (OCI-LY10 and U2932) resulted in G0/G1 cell cycle arrest, increased apoptosis, and decreased invasiveness. miRNA target prediction programs...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:04
Modulation of ERQC and ERAD: A Broad-Spectrum Spanner in the Works of Cancer Cells?
Authors: Tax G, Lia A, Santino A, Roversi P Abstract Endoplasmic reticulum glycoprotein folding quality control (ERQC) and ER-associated degradation (ERAD) preside over cellular glycoprotein secretion and maintain steady glycoproteostasis. When cells turn malignant, cancer cell plasticity is affected and supported either by point mutations, preferential isoform selection, altered expression levels, or shifts to conformational equilibria of a secreted glycoprotein. Such changes are crucial...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:04
Gastric Cancer in the Era of Immune Checkpoint Blockade.
Authors: Figueroa-Protti L, Soto-Molinari R, Calderón-Osorno M, Mora J, Alpízar-Alpízar W Abstract Gastric cancer (GC) is one of the most important malignancies worldwide because of its high incidence and mortality. The very low survival rates are mainly related to late diagnosis and limited treatment options. GC is the final clinical outcome of a stepwise process that starts with a chronic and sustained inflammatory reaction mounted in response to Helicobacter pylori infection. The bacterium...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 22:04
Most Americans Who Think They ’ re Allergic to Penicillin Aren ’ t, Study Finds
BOSTON (CBS)- Think you’re allergic to penicillin?  Chances are…you’re not.  In fact, more than 30 million people in the United States wrongly believe they’re allergic to penicillin. Many people report that they’re allergic to penicillin, or amoxicillin, or one of the other penicillin’s, often saying they’re mom told them they had some type of reaction when they were little. So many doctors turn to other types of antibiotics to treat common ailments like strep throat or ear infections, which may...
MedWorm Allergy & Immunology News
Wed Oct 30, 2019 22:57
Analysis of a Multiple Delays Model for Treatment of Cancer with Oncolytic Virotherapy.
Authors: El Alami Laaroussi A, Hia ME, Rachik M, Ghazzali R Abstract Despite advanced discoveries in cancerology, conventional treatments by surgery, chemotherapy, or radiotherapy remain ineffective in some situations. Oncolytic virotherapy, i.e., the involvement of replicative viruses targeting specific tumor cells, opens new perspectives for better management of this disease. Certain viruses naturally have a preferential tropism for the tumor cells; others are genetically modifiable to...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:37
Correlation-Based Ensemble Feature Selection Using Bioinspired Algorithms and Classification Using Backpropagation Neural Network.
Authors: Elgin Christo VR, Khanna Nehemiah H, Minu B, Kannan A Abstract A framework for clinical diagnosis which uses bioinspired algorithms for feature selection and gradient descendant backpropagation neural network for classification has been designed and implemented. The clinical data are subjected to data preprocessing, feature selection, and classification. Hot deck imputation has been used for handling missing values and min-max normalization is used for data transformation. Wrapper...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:37
A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer
Publication date: Available online 30 October 2019Source: Nanomedicine: Nanotechnology, Biology and MedicineAuthor(s): María Victoria Cano-Cortés, Saúl Abenhamar Navarro-Marchal, María Paz Ruiz-Blas, Juan José Díaz-Mochón, Juan Antonio Marchal, Rosario M. Sánchez-MartínAbstractA novel chemical-based orthogonal bioconjugation strategy to produce tri-functionalised nanoparticles (NPs) carrying doxorubicin (DOX), near-infrared cyanine dye (Cy7) and a homing peptide CRGDK, a peptide specifically binds...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:14
Selective nano-thermal therapy of human retinoblastoma in retinal laser surgery
Publication date: Available online 31 October 2019Source: Nanomedicine: Nanotechnology, Biology and MedicineAuthor(s): Ramin Khademi, Abolhassan RazminiaAbstractIn this research, an experimental validated predictive finite element model of a cancerous human eye is developed to investigate how the tumor cells in retinoblastoma can be selectively damaged in the course of laser irradiation. In the computational modeling, the tumor is assumed to be in the initial growth stages and located in the macular...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:14
Doxorubicin eluting microporous polysaccharide scaffolds: An implantable device to expunge tumour
Publication date: February 2020Source: Materials Science and Engineering: C, Volume 107Author(s): GU Preethi, J Sreekutty, BS Unnikrishnan, MG Archana, HP Syama, Mohan Deepa, R Shiji, KS Anusree, TT SreelekhaAbstractA variety of naturally derived and synthetic biomaterial scaffolds have been investigated as 3D environments for supporting cell growth and can be used to achieve drug delivery with high loading efficiency. Polysaccharides which enhance the tumour-specific drug release are ideal candidates...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:11
Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance
Publication date: February 2020Source: Materials Science and Engineering: C, Volume 107Author(s): Julia C. Fontoura, Christian Viezzer, Fabiana G. dos Santos, Rosane A. Ligabue, Ricardo Weinlich, Renato D. Puga, Dyeison Antonow, Patricia Severino, Cristina BonorinoAbstractIn vitro drug screening is widely used in the development of new drugs, because they constitute a cost-effective approach to select compounds with more potential for therapy. They are also an attractive alternative to in vivo testing....
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:11
Quality of Life in Patients With Breast Cancer: The Influence of Family Caregiver's Burden and the Mediation of Patient's Anxiety and Depression
Previous research showed that family caregiver's perception of burden can influence patient's report on their quality of life (QoL). The present study investigated the relationship between the two variables by considering the role of patient's anxiety and depression. A total of 382 dyads of Chinese breast cancer patients and their family caregivers participated in this study. The results showed that the mediation model fitted the data well (χ2 = 49.859; df = 16; χ2/df = 3.116; RMSEA = 0.05; TLI =...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:09
Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity
Publication date: 29 October 2019Source: Cell Reports, Volume 29, Issue 5Author(s): Linda Schadt, Colin Sparano, Nicole Angelika Schweiger, Karina Silina, Virginia Cecconi, Giulia Lucchiari, Hideo Yagita, Emilien Guggisberg, Sascha Saba, Zuzana Nascakova, Winfried Barchet, Maries van den BroekSummarySensing of cytoplasmic DNA by cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) results in production of the dinucleotide cGAMP and consecutive activation of stimulator of...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:05
Mapping Native R-Loops Genome-wide Using a Targeted Nuclease Approach
Publication date: 29 October 2019Source: Cell Reports, Volume 29, Issue 5Author(s): Qingqing Yan, Emily J. Shields, Roberto Bonasio, Kavitha SarmaSummaryR-loops are three-stranded DNA:RNA hybrids that are implicated in many nuclear processes. While R-loops may have physiological roles, the formation of stable, aberrant R-loops has been observed in neurological disorders and cancers. Current methods to assess their genome-wide distribution rely on affinity purification, which is plagued by large input...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:05
Transcriptional Signature Derived from Murine Tumor-Associated Macrophages Correlates with Poor Outcome in Breast Cancer Patients
Publication date: 29 October 2019Source: Cell Reports, Volume 29, Issue 5Author(s): Sander Tuit, Camilla Salvagno, Theodore S. Kapellos, Cheei-Sing Hau, Lea Seep, Marie Oestreich, Kathrin Klee, Karin E. de Visser, Thomas Ulas, Joachim L. SchultzeSummaryTumor-associated macrophages (TAMs) are frequently the most abundant immune cells in cancers and are associated with poor survival. Here, we generated TAM molecular signatures from K14cre;Cdh1flox/flox;Trp53flox/flox (KEP) and MMTV-NeuT (NeuT) transgenic...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:05
Resistance to BET Inhibitor Leads to Alternative Therapeutic Vulnerabilities in Castration-Resistant Prostate Cancer
Publication date: 29 October 2019Source: Cell Reports, Volume 29, Issue 5Author(s): Aishwarya Pawar, Paradesi Naidu Gollavilli, Shaomeng Wang, Irfan A. Asangani (Source: Cell Reports)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:05
Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism
Publication date: 29 October 2019Source: Cell Reports, Volume 29, Issue 5Author(s): Alex J. Bott, Jianliang Shen, Claudia Tonelli, Le Zhan, Nithya Sivaram, Ya-Ping Jiang, Xufen Yu, Vrushank Bhatt, Eric Chiles, Hua Zhong, Sara Maimouni, Weiwei Dai, Stephani Velasquez, Ji-An Pan, Nathiya Muthalagu, Jennifer Morton, Tracy G. Anthony, Hui Feng, Wouter H. Lamers, Daniel J. MurphySummaryGlutamine is thought to play an important role in cancer cells by being deaminated via glutaminolysis to α-ketoglutarate...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 21:05
miR ‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma.
In conclusion, our findings indicate that miR‑486 may serve as a novel prognostic biomarker but may also be applied as a new therapeutic approach for the treatment of RCC. PMID: 31661131 [PubMed - as supplied by publisher] (Source: Molecular Medicine Reports)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 20:52
Cannabinoid receptor 2 ‑selective agonist JWH015 attenuates bone cancer pain through the amelioration of impaired autophagy flux induced by inflammatory mediators in the spinal cord.
Cannabinoid receptor 2‑selective agonist JWH015 attenuates bone cancer pain through the amelioration of impaired autophagy flux induced by inflammatory mediators in the spinal cord. Mol Med Rep. 2019 Oct 25;: Authors: Mao Y, Huang Y, Zhang Y, Wang C, Wu H, Tian X, Liu Y, Hou B, Liang Y, Rong H, Gu X, Ma Z Abstract Bone cancer pain (BCP) is a severe complication of advanced bone cancer. Although cannabinoid receptor 2 (CB2) agonists may have an analgesic effect, the underlying...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 20:52
miR ‑593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways.
In conclusion, these results indicated that miR‑593 may act as a tumor suppressor in NSCLC to decelerate cancer aggressiveness by inhibiting SLUG expression. PMID: 31661137 [PubMed - as supplied by publisher] (Source: Molecular Medicine Reports)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 20:52
Prognostic implications of aberrantly expressed methylation ‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
In conclusion, a prognostic risk model for HCC is proposed based on the bioinformatic analysis of methylation‑driven genes. The findings of the present study may improve understanding of the pathogenesis and prognosis of HCC. PMID: 31661127 [PubMed - as supplied by publisher] (Source: Molecular Medicine Reports)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 20:52
Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
In conclusion, serum miR‑508‑3p and miR‑885‑5p are novel potential biomarkers for the diagnosis of ccRCC. PMID: 31661117 [PubMed - as supplied by publisher] (Source: Molecular Medicine Reports)
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 20:52
Gene targets of sulforaphane in head and neck squamous cell carcinoma.
Authors: Hu L, Li H, Lee ED, Grandis JR, Bauman JE, Johnson DE Abstract Patients who have undergone curative‑intent therapy for head and neck squamous cell carcinoma (HNSCC) exhibit a high rate of development of second primary tumors (SPTs), which are frequently lethal. A chemoprevention strategy that prevents SPTs would have a major impact on patient outcomes. Sulforaphane, a naturally‑occurring compound derived from cruciferous vegetables exhibits chemopreventive activity against HNSCC...
MedWorm Cancer & Oncology Research
Thu Oct 31, 2019 20:52

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου